WHO Sounds Alert Over Acute Shortage of Weight-Loss Injections

Less than one in 10 patients that would benefit from obesity jabs such as Wegovy can access them, warns the WHO as it publishes its inaugural recommendations on the therapies.

Considering more than one billion individuals worldwide currently living with obesity, it is calling for increased and just availability to this class of drugs.

According to estimates, in excess of 2,000,000,000 will be obese by 2030 unless action is taken.

"The latest guidance affirms that excess weight is a lifelong illness that can be treated with comprehensive and ongoing care," remarked its chief Tedros Adhanom Ghebreyesus.

Significant expense, limited production capacity, and supply-chain constraints are significant obstacles to universal availability to the injections that can aid individuals in losing substantial body mass, explains the body.

GLP-1 Therapy Shortage

Despite the present most favorable outlook, the manufacturing of these medications might only reach around 100 million people – under 10% of the global need, per the health organization.

The guideline encourages governments and firms to expand access, via measures like licensing agreements.

Exclusive production rights on the active ingredient – the primary component of the drug Wegovy – is due to expire in a number of countries in 2026.

The Way Weight-Loss Injections Operate

These medications mimick a biological compound to delay gastric emptying, curb appetite and enhance satiety so users consume fewer calories.

Individuals typically start to lose weight in the initial weeks of starting on the weekly injections.

Evidence points to people may put most of the weight back on after a year of stopping the drug, because their typical food cravings resume.

Being overweight or obese elevates your likelihood for contracting health problems, including type 2 diabetes, heart disease, brain attack, and specific cancers.

Obesity impacts people in all nations and was linked to over three and a half million deaths worldwide in 2024, according to the WHO.